Cytochrome P-450 CYP2C9 Substrates
DBCAT002634Pharmacologic class
A DrugBank category of 290 drugs. 253 of them are approved.
- Part of
- Cytochrome P-450 Substrates
- Also known as
- CYP2C9 Substrates · Cytochrome P-450 CYP2C9-Substrates
- Drugs
- (R)-warfarin
- (S)-Warfarin
- 5-Methoxy-N,N-diisopropyltryptamine
- Abrocitinib
- Aceclofenac
- Acenocoumarol
- Acetohexamide
- Acetylsalicylic acid
- Adagrasib
- Aficamten
- Alosetron
- Alprazolam
- Aminophenazone
- Amitriptyline
- Amprenavir
- Antipyrine
- Apixaban
- Arachidonic Acid
- Arformoterol
- Arketamine
- Artemether
- Asunaprevir
- Atazanavir
- Avanafil
- Avapritinib
What you can answer from here — as of September 19, 2019
Which targets do Cytochrome P-450 CYP2C9 Substrates share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account